4//SEC Filing
Simson Jake 4
Accession 0001209191-22-035081
CIK 0001645569other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 5:01 PM ET
Size
6.4 KB
Accession
0001209191-22-035081
Insider Transaction Report
Form 4
Simson Jake
Director
Transactions
- Award
Stock Option (right to buy Common Stock)
2022-06-07+21,250→ 21,250 totalExercise: $14.98Exp: 2032-06-06→ Common Stock (21,250 underlying)
Footnotes (2)
- [F1]The option vests on the earlier to occur of: (i) the one-year anniversary of the grant date and (ii) the subsequent annual meeting of the Registrant's stockholders, in each case, subject to the Reporting Holder's continued service to the Registrant.
- [F2]Under the Reporting Holder's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Holder holds the stock option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund") and the RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The Reporting Holder is obligated to turn over to the Adviser any net cash or stock received upon exercise of the stock option, which will offset advisory fees owed by the Fund and the Nexus Fund II. The Reporting Holder therefore disclaims beneficial ownership of the stock option and underlying Common Stock.
Documents
Issuer
DICE Therapeutics, Inc.
CIK 0001645569
Entity typeother
Related Parties
1- filerCIK 0001863094
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 5:01 PM ET
- Size
- 6.4 KB